Free Trial

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Trading 0.8% Higher - Here's Why

RHÖN-KLINIKUM Aktiengesellschaft logo with Medical background

Key Points

  • RHÖN-KLINIKUM Aktiengesellschaft's stock experienced a slight increase of 0.8%, closing at €12.00 ($13.64) after trading.
  • The company has a market capitalization of $790.92 million and a P/E ratio of 17.63.
  • RHÖN-KLINIKUM provides a variety of healthcare services, including treatment for rehabilitation, ophthalmology, and heart diseases across its hospitals in Germany.
  • MarketBeat previews the top five stocks to own by September 1st.

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK - Get Free Report)'s stock price traded up 0.8% during trading on Thursday . The stock traded as high as €12.00 ($13.95) and last traded at €12.00 ($13.95). 46 shares changed hands during mid-day trading, a decline of 100% from the average session volume of 43,281 shares. The stock had previously closed at €11.90 ($13.84).

RHÖN-KLINIKUM Aktiengesellschaft Price Performance

The company's 50 day simple moving average is €12.32 and its 200 day simple moving average is €13.53. The firm has a market cap of $790.92 million, a price-to-earnings ratio of 17.63, a P/E/G ratio of 26.77 and a beta of -0.13.

RHÖN-KLINIKUM Aktiengesellschaft Company Profile

(Get Free Report)

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases.

Featured Articles

Should You Invest $1,000 in RHÖN-KLINIKUM Aktiengesellschaft Right Now?

Before you consider RHÖN-KLINIKUM Aktiengesellschaft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RHÖN-KLINIKUM Aktiengesellschaft wasn't on the list.

While RHÖN-KLINIKUM Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines